A screening method for biotinidase deficiency in newborns.

We describe a method for neonatal screening for biotinidase (EC 3.5.1.12) deficiency. Biotinidase activity is assessed colorimetrically from dried samples of whole blood spotted on the same filter papers as used in the neonatal screening for phenylketonuria. After the reaction, samples from normal infants are characteristically purple, whereas those from affected individuals are straw-colored. To confirm the deficiency, the enzyme is quantitatively assayed in additional blood spots or serum. A pilot study has been initiated with samples obtained by the Commonwealth of Virginia for phenylketonuria testing.

[1]  B. Wolf,et al.  A sensitive radioassay for biotinidase activity: deficient activity in tissues of serum biotinidase-deficient individuals. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[2]  W. Parker,et al.  Phenotypic variation in biotinidase deficiency. , 1983, The Journal of pediatrics.

[3]  G. Feldman,et al.  The biotin-dependent carboxylase deficiencies. , 1982, American journal of human genetics.

[4]  W. H. Peterson,et al.  The enzymatic degradation of soluble bound biotin. , 1954, The Journal of biological chemistry.

[5]  E. Marshall,et al.  Determination of Sulfanilamide in Blood and Urine , 1937 .